-
公开(公告)号：US10526417B2
公开(公告)日：2020-01-07
申请号：US14952786
申请日：2015-11-25
Applicant: Xencor, Inc.
Inventor： Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal
Abstract: The present invention is directed to heterodimeric antibodies that bind CD3 and CD38.
-
公开(公告)号：US09822186B2
公开(公告)日：2017-11-21
申请号：US14673695
申请日：2015-03-30
Applicant: Xencor, Inc.
Inventor： Matthew Bernett , Seung Chu , Gregory Moore , John Desjarlais
CPC classification number: C07K16/468 , C07K16/2809 , C07K16/2896 , C07K16/30 , C07K2317/24 , C07K2317/31 , C07K2317/52 , C07K2317/55 , C07K2317/565 , C07K2317/622 , C07K2317/64 , C07K2317/73 , C07K2317/92 , C07K2317/94
Abstract: The invention provides novel heterodimeric proteins including heterodimeric antibodies.
-
公开(公告)号：US20160355608A1
公开(公告)日：2016-12-08
申请号：US15141350
申请日：2016-04-28
Applicant: Xencor, Inc.
Inventor： Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal , Sung-Hyung Lee
CPC classification number: C07K16/468 , A61K2039/505 , C07K16/2809 , C07K16/2866 , C07K16/2887 , C07K16/2896 , C07K16/30 , C07K16/3061 , C07K16/40 , C07K2317/24 , C07K2317/31 , C07K2317/35 , C07K2317/515 , C07K2317/52 , C07K2317/522 , C07K2317/526 , C07K2317/528 , C07K2317/55 , C07K2317/565 , C07K2317/60 , C07K2317/622 , C07K2317/64 , C07K2317/70 , C07K2317/73 , C07K2317/92 , C07K2317/94
Abstract: The present invention is directed to novel heterodimeric antibodies.
-
公开(公告)号：US20160215063A1
公开(公告)日：2016-07-28
申请号：US14952786
申请日：2015-11-25
Applicant: Xencor, Inc.
Inventor： Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal
Abstract: The present invention is directed to heterodimeric antibodies that bind CD3 and CD38.
Abstract translation: 本发明涉及结合CD3和CD38的异二聚体抗体。
-
公开(公告)号：US12180302B2
公开(公告)日：2024-12-31
申请号：US17233083
申请日：2021-04-16
Applicant: Xencor, Inc.
Inventor： John Desjarlais , Alex Nisthal , Seung Chu
Abstract: The present invention relates to novel antigen binding domains and heterodimeric antibodies that bind Fibroblast Activation Protein (FAP).
-
Patent Agency Ranking
公开(公告)号：US20230365717A1
公开(公告)日：2023-11-16
申请号：US18308623
申请日：2023-04-27
Applicant: Xencor, Inc.
Inventor： Matthew Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal , Sung-Hyung Lee
CPC classification number: C07K16/468 , C07K16/2809 , C07K16/2896 , C07K16/30 , C07K16/2818 , C07K16/3061 , A61K2039/505
Abstract: The present invention is directed to novel heterodimeric antibodies.
-
公开(公告)号：US20220162343A1
公开(公告)日：2022-05-26
申请号：US17542342
申请日：2021-12-03
Applicant: Xencor, Inc.
Inventor： Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal , Sung-Hyung Lee
Abstract: The present invention is directed to novel heterodimeric antibodies.
-
公开(公告)号：US20200317814A1
公开(公告)日：2020-10-08
申请号：US16805453
申请日：2020-02-28
Applicant: Xencor, Inc.
Inventor： Rumana Rashid , Umesh S. Muchhal , Gregory Moore , Alex Nisthal , Seung Chu , Sung-Hyung Lee , Yoon Kyung Kim
Abstract: The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (ENPP3).
-
公开(公告)号：US20200216559A1
公开(公告)日：2020-07-09
申请号：US16489539
申请日：2016-12-07
Applicant: Xencor, Inc.
Inventor： Gregory Moore , John Desjarlais , Seung Chu
Abstract: The present invention is directed to heterodimeric antibodies that bind CD3 and PSMA.
-
公开(公告)号：US10259887B2
公开(公告)日：2019-04-16
申请号：US15141350
申请日：2016-04-28
Applicant: Xencor, Inc.
Inventor： Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal , Sung-Hyung Lee
Abstract: The present invention is directed to novel heterodimeric antibodies.
-
-
-
-
-
-
-
-
-
Search Results
50
records
(took 0.022 seconds)
